结合化疗是一种结合化疗
1Department of Pediatric Hematology, School of Medicine, Ege University, Izmir, Turkey.
Annals of the New York Academy of Sciences
|August 18, 2023
概括
结合合疗法为输血依赖的血病患者提供了一种灵活的方法. 现实世界的数据突出显示,患者遵守是有效减少这些先进的铁化策略的铁过载的关键.
科学领域:
- 血液学 血液学 血液学
- 药理学 药理学是指药理学的学科.
- 内部医学 内部医学
背景情况:
- 输血依赖性沙拉西米亚需要铁化疗法以防止器官损伤.
- 对一些患者来说,单一治疗可能是不够的,需要加强或组合的方法.
- 个性化化方案可以改善患者的治疗结果和生活质量.
研究的目的:
- 评估结合化疗法在输血依赖性血病中的作用和有效性.
- 探索组合不同铁化剂的灵活性和潜在好处.
- 评估组合治疗对铁平衡,耐受性和固性的影响.
主要方法:
- 对联合铁化疗法的临床研究和现实生活数据的审查.
- 对各种剂量方案的分析,包括同时,顺序和交替的药物管理.
- 组合治疗和单一治疗之间的结局结果的比较.
主要成果:
- 临床研究证实了已知化组合的安全性和有效性.
- 现实数据表明,合规性显著影响了组合治疗中铁过载的减少.
- 组合疗法允许个性化治疗计划,可能提高耐受性和坚持性.
结论:
- 结合化疗是一种可行的策略,用于输血依赖的血病患者与耐火铁过载.
- 优化患者的遵从性对于最大限度地发挥结合铁化疗法的益处至关重要.
- 个性化组合疗法可以改善治疗坚持和生活质量,在管理铁过载时.
更多相关视频
12:59A Study of the Complexation of MercuryII with Dicysteinyl Tetrapeptides by Electrospray Ionization Mass Spectrometry
Published on: January 8, 2016
8.0K
09:49Dual-phase Cone-beam Computed Tomography to See, Reach, and Treat Hepatocellular Carcinoma during Drug-eluting Beads Transarterial Chemo-embolization
Published on: December 2, 2013
10.4K
相关概念视频
Complexation Equilibria: The Chelate Effect
551
In complexation reactions, metal atoms or cations interact with ligands to form donor-acceptor adducts called metal complexes. Ligands that bind through one donor site are monodentate, ligands with two donor sites are bidentate, and those with more than two donor sites are polydentate ligands. For example, ethylene diamine is a bidentate ligand that binds through two nitrogen donor atoms, forming a five-membered ring. EDTA is a polydentate ligand that binds through four oxygen and two nitrogen...
551
EDTA: Chemistry and Properties
2.0K
Polydentate ligands are most widely used in complexometric titrations because they form more stable complexes with the metal ions than mono- or bidentate ligands due to the chelate effect. Examples of polydentate ligands are ethylenediaminetetraacetic acid (EDTA), crown ethers, and cryptands. The most important feature of optimal polydentate ligands is the ability to form 1:1 complexes in a single-step process. Amino carboxylic acid derivatives are frequently used as complexing agents. EDTA is...
2.0K
Extraction: Advanced Methods
483
Metal ions can be separated from one another by complexation with organic ligands–the chelating agent– to form uncharged chelates. Here, the chelating agent must contain hydrophobic groups and behave as a weak acid, losing a proton to bind with the metal. Since most organic ligands used in this process are insoluble or undergo oxidation in the aqueous phase, the chelating agent is initially added to the organic phase and extracted into the aqueous phase. The metal-ligand complex is...
483
Masking and Demasking Agents
2.5K
EDTA titrations may necessitate masking and demasking agents to temporarily protect a particular metal ion in a mixture from the EDTA reaction. These agents facilitate the sequential analysis of the metal ions by forming stable complexes with some—but not all—metal ions during certain steps.
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
2.5K
Anticholinesterase Agents: Poisoning and Treatment
920
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
920
Antidotes
684
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
684
